The Application Effect of Yigong Granule combined with Oxytocin in Patients with Uterine Involution After Cesarean Section

Abstract

Abstract: Objective To analyze the application of Yigong granule combined with oxytocin in the treatment of patients with uterine involution after cesarean section and its effect on lactation. Methods The clinical data of 100 patients with uterine involution after cesarean section who were admitted to the First People's Hospital of Pingyuan County from January 2018 to December 2020 were selected for retrospective analysis, and divided into observation group (using Yigong Granule combined with oxytocin treatment, a total of 50 cases) and the control group (with oxytocin treatment, a total of 50 cases). The clinical efficacy, incidence of adverse reactions, daily milk production, average lochia volume, and disappearance time of low back and abdominal pain were compared between the two groups after one week of treatment. Finally, the changes in hormone levels before and after treatment were compared between the two groups. Results The clinical efficacy of the observation group was significantly higher than that of the control group (P<0.05); the daily lactation amount of the observation group was significantly higher than that of the control group after 1 week of medication (P<0.05), and the average amount of lochia, waist and abdominal pain disappeared time and other indicators were lower than those in the control group (P<0.05); there was no statistical significant difference in the adverse drug reaction incidence rate between the two groups (P>0.05); the differences in follicle-stimulating hormone, luteinizing hormone, estradiol, and progesterone between the two groups before treatment No significance (P>0.05), follicle-stimulating hormone, luteinizing hormone and estradiol in the observation group were higher than those in the control group (P<0.05), and progesterone was lower than that in the control group (P<0.05). Conclusion Yigong granule combined with oxytocin has a high curative effect, which helps to accelerate the involution of the uterus, relieve the symptoms of lochia and low back and abdominal pain, and at the same time helps to increase the milk production of the puerpera without increasing the adverse drug reactions. It is worthy of popularization and application.

Key words: Yigong Granules, oxytocin, uterine involution after cesarean section

CLC Number:

R714.6

XIN Xing. The Application Effect of Yigong Granule combined with Oxytocin in Patients with Uterine Involution After Cesarean Section[J]. ZHONGHUA YANGSHENG BAOJIAN, 2022, 40(21): 17-19.

References

[1] 冯晓云,韩冰,徐桂冉,等.缩宫素联合马来酸麦角新碱预防宫缩乏力产后出血的疗效及安全性探讨[J].解放军预防医学杂志,2019, 37(1):111-113.
[2] 杨艳芬,卢丽敏.欣母沛与马来酸麦角新碱对阴道分娩产后出血的预防效果及子宫复旧的影响[J].中国妇产科临床杂志,2019,20(3):258-259.
[3] 谢杏,孔北华,段涛,等.妇产科学(第9版)[M].北京:人民教育出版社,2018:214-215.
[4] 薛清杰,王永淑.缩宫素联合益母草注射液对产后出血的预防作用及促子宫复旧效果研究[J].陕西中医,2018,39(7):833-835.
[5] 郭静,王建军,童晓文,等.缩宫素联合鲜益母草胶囊及缩宫素联合五加生化胶囊治疗产后子宫复旧不良的临床疗效比较[J].中国性科学,2018,27(6):124-127.
[6] 马艳华,梁旭霞,马银瑶.复方益母草口服液与缩宫素预防产后出血的效果及对应.激反应的影响[J].解放军预防医学杂志,2018,36(2): 258-260,282.
[7] 刘红艳. 马来酸麦角新碱联合缩宫素对阴道分娩产妇产后出血及子宫复旧的影响[J].中国合理用药探索,2019,16(8):144-146.
[8] 郭晔,贾蓉.卡前列素氨丁三醇联合缩宫素预防瘢痕子宫剖宫产产后出血的效果及对子宫复旧的影响[J].临床医学研究与实践,2019,4(1):122-123.
[9] 王晓梅. 益宫颗粒联合缩宫素对剖宫产产后出血的治疗效果分析[J].中国实用医药,2021,16(2):147-149.
[10] 张菁华. 屈螺酮炔雌醇片联合益宫颗粒及抗生素对人工流产术后女性月经恢复及子宫内膜厚度的影响[J].国际医药卫生导报,2020, 26(6):753-755.
[11] 高宁宁. 益宫颗粒联合缩宫素对剖宫产产后出血的临床应用效果研究[J].中国现代药物应用,2020,14(8):173-175.
[12] 史淑慧. 益宫颗粒联合缩宫素注射液在初产妇剖宫产分娩产后宫腔积血中的应用[J].中国合理用药探索,2019,16(10):170-172.
[13] 陈怡. 卡前列素氨丁三醇、麦角新碱、缩宫素三联疗法预防产后出血的临床疗效观察[J].中国妇幼保健,2018,33(6):1266-1268.
[14] 王海会,万瑞,郑稳,等.益宫颗粒联合卡前列素氨丁三醇治疗产后出血的临床研究[J].现代药物与临床,2021,36(1):157-160.
[15] 刘茂永,黄露,龚乾涛,等.益宫颗粒联合缩宫素治疗剖宫产术后子宫复旧不全临床效果及对泌乳的影响[J].中华中医药学刊,2020, 38(7):81-83.
[16] 李桃英,高珊珊,刘鹏森,等.加味生化汤联合益宫颗粒治疗血瘀型产后恶露不绝[J].中医学报,2018,33(7):1322-1324.
[17] 欧琳霞,马瑜,钟凤花.卡前列素氨丁三醇联合缩宫素预防产后出血以及促进子宫恢复的价值[J].甘肃医药,2020,39(9):819-821.
[18] 宗方,陈莹莹,赵英姿,等.益母草联合缩宫素促进剖宫产子宫复旧、预防产后出血的效果及产后出血影响因素分析[J].临床误诊误治,2019,32(10):56-60.